Zujian Hu
Zhejiang Key Laboratory Of Intelligent Cancer Biomarker Discovery And Translation
Wenzhou, 325035, China
Wenzhou, 325035, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
Enhanced oral nanomedicine utilizing biomineralized oncolytic virus for synergistic gastrointestinal cancer therapy.
Journal: Materials today. Bio
Published: September 14, 2025
Dorsomorphin Suppresses EMT to Reduce AR-Negative Prostate Cancer Metastasis by Synergistically Antagonizing JAK2/STAT3 and Gli2-Independent Shh Activation.
Journal: Prostate cancer
Published: January 15, 2025
Fraxetin attenuates DNA damage and inflammation in cisplatin-induced nephrotoxicity via FoxO1 activation.
Journal: International immunopharmacology
Published: September 18, 2024
Investigating the impact of inflammatory response-related genes on renal fibrosis diagnosis: a machine learning-based study with experimental validation.
Journal: Journal of biomolecular structure & dynamics
Published: February 21, 2024
Development and Validation of a Diagnostic Model for AKI Based on the Analysis of Ferroptosis-related Genes.
Journal: Current medicinal chemistry
Published: January 29, 2024
Smad4 regulates TGF-β1-mediated hedgehog activation to promote epithelial-to-mesenchymal transition in pancreatic cancer cells by suppressing Gli1 activity.
Journal: Computational and structural biotechnology journal
Published: November 11, 2023
Characterization of a predictive signature for tumor microenvironment and immunotherapy response in hepatocellular carcinoma involving neutrophil extracellular traps.
Journal: Heliyon
Published: September 18, 2023
S100A2 induces epithelial-mesenchymal transition and metastasis in pancreatic cancer by coordinating transforming growth factor β signaling in SMAD4-dependent manner.
Journal: Cell death discovery
Published: August 03, 2023
Fraxetin pretreatment alleviates cisplatin-induced kidney injury by antagonizing autophagy and apoptosis via mTORC1 activation.
Journal: Phytotherapy research : PTR
Published: May 18, 2023
STAT3 inhibition enhances gemcitabine sensitivity in pancreatic cancer by suppressing EMT, immune escape and inducing oxidative stress damage.
Journal: International immunopharmacology
Published: May 12, 2023
Targeted inhibition of mTOR by BML-275 induces mitochondrial-mediated apoptosis and autophagy in prostate cancer.
Journal: European journal of pharmacology
Published: April 21, 2023
Last Updated: 09/26/2026